Výsledky vyhledávání

4CPS-248 Therapeutic drug monitoring of linezolid in soft-tissue and osteoarticular infections: a retrospective analysis

Autor: A Gracia Moya, MB Guembe Zabaleta, J Gomez Alonso, M Miarons Font, S Garcia Garcia, AG Arevalo Bernabe, MD Rodriguez Pardo, JC Juarez Gimenez, JB Montoro Ronsano, P Lalueza Broto, MQ Gorgas Torner

Publikováno v: Late breaking abstracts.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6ad69eee2ff9a8f83475b201f1ea4643
https://doi.org/10.1136/ejhpharm-2023-eahp.430

Zobrazit plný text záznamu

4CPS-086 Inhaled sedation with halogenated agents in the intensive care unit: a literature mini-review

Autor: JM Del Río Gutiérrez, L Domenech Moral, HC Garcia Diaz, P Sanchez Sancho, P Lalueza Broto, RS Contreras Medina, A Gracia Moya, AG Arevalo Bernabe, A Puertas Sanjuan, J Santander Revoreda, JC Juarez Gimenez

Publikováno v: Section 4: Clinical pharmacy services.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::61ab0d3068557902460bfe319070fcbf
https://doi.org/10.1136/ejhpharm-2022-eahp.119

Zobrazit plný text záznamu

5PSQ-012 Drug interactions and polypharmacy in a cohort of HIV positive haemophiliac patients

Autor: E Ribera, AG Arevalo, P Sanchez-Sancho, JC Juarez, P Lalueza, MQ Gorgas, P Gonzalez-Moreno

Publikováno v: Section 5: Patient Safety and Quality assurance.

Background and importance The haemophiliac population is getting older and therefore they need to confront other comorbidities in addition to those associated with congenital coagulopathy. Aim and objectives To determine the complete pharmacological

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5d8160751aef8a409361a12e5c98829a
https://doi.org/10.1136/ejhpharm-2020-eahpconf.329

Zobrazit plný text záznamu

4CPS-130 Use of non-specific immunoglobulins in burned paediatric patients: validation of the protocol of a tertiary hospital

Autor: JC Juarez, R Rossich, Z Martínez, L Betriu Sebastia, E Serramontmany, J Balcells, AG Arevalo, P Lalueza, MJ Cabañas

Publikováno v: Eur J Hosp Pharm

Background Serious burns produce plasma extravasation which develops an important loss of immunoglobulins (Ig). In patients with a burned surface area (BSA) >15% IgG plasmatic levels decrease until 40 hours’ post-burn. Purpose To evaluate the use o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::169b65597d02e5acdd99ade2568beb8a
https://europepmc.org/articles/PMC7535152/

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání